Brand Name: Neoceptin R 150
Manufacturer: Beximco Pharmaceuticals Limited.
Neoceptin® R
Ranitidine Tablet
Description
The active ingredient of Neoceptin R is Ranitidine. Neoceptin R is a histamine H2 receptor antagonist. It inhibits basal and stimulated secretion of gastric acid. Neoceptin R is rapidly absorbed after oral
administration. Food or antacid does not interfere its absorption.
Indications
Neoceptin R is indicated for the treatment of duodenal ulcer, benign gastric ulcer, post-operative ulcer, reflux oesophagitis, Zollinger Ellison syndrome and in other conditions where reduction of gastric acidity is beneficial.
Dosage and Administration
-
Duodenal and gastric ulcer : The usual dosage is 150 mg twice daily taken in
the morning and evening or 300 mg as a single daily dose at night for 4
to 8 weeks. -
Reflux oesophagitis : 150 mg twice daily or 300 mg at bed time for up to 8
weeks. -
Zollinger Ellison syndrome : 150 mg 3 times daily and increased if necessary
up to 6 g daily in divided doses. Dosage should be continued as long as
clinically indicated. -
Episodic dyspepsia : 150 mg twice daily or 300 mg at bed time for up to 6
weeks. - Maintenance : 150 mg at night for preventing recurrences.
- Child (peptic ulcer) : 2-4 mg/kg twice daily, maximum 300 mg daily.
Precautions
Ranitidine should be given in reduced dosage to patients with impaired renal and hepatic function.
Side Effects
Neoceptin R is well tolerated and side effects are usually uncommon.Altered bowel habit, dizziness, rash, tiredness, reversible confusional states, headache, decreased blood counts, muscle or joint pain have rarely been reported.
Reviews
There are no reviews yet.